Microbotox for Lower Face Rejuvenation

Launched by ST JOSEPH UNIVERSITY, BEIRUT, LEBANON · Jun 13, 2017

Keywords

ClinConnect Summary

The abobotulinumtoxinA will be used for the intervention. The abobotulinumtoxinA will be prepared by adding 2.5 cc of normal saline to a 500-unit Dysport© (Ipsen Ltd, Berks, UK) vial. Further dilution to the appropriate Microbotox concentration will be done in the syringe itself. Each 1mL syringe of Microbotox solution will contain 20-28 units of onabotulinumtoxinA per mL of solution.

Preinjection frontal, oblique and lateral patient pictures will be taken (at rest and with contraction)

Injection points:

A series of 100-150 intradermal microdroplets injection points 1 cm apart will be de...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• Female patients presenting to our clinic for neck rejuvenation who:
• • Were deemed nonsurgical candidates for neck rejuvenation
• • Were not willing to undergo invasive surgical procedures
• • Had a medical contraindication to surgery
• Exclusion Criteria:
• • Patients with lower face botulinum toxin injection in the past 12 months
• • Patients with resorbable lower face fillers injection in the past 12 months
• • Patients with previous permanent lower face fillers injection
• • Pregnant patients
• • Lactating patients
• • Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert syndrome)
• • Patients using medication that could potentiate the effect of botulinum (ex: aminoglycoside antibiotics)
• • Patients with sensitivity to botulinum toxin or human albumin